Mentioned in this article
Prometheus Biosciences Inc (RXDX) is near the top in its industry group according to InvestorsObserver. RXDX gets an overall rating of 67. That means it scores higher than 67 percent of stocks. Prometheus Biosciences Inc gets a 74 rank in the Biotechnology industry. Biotechnology is number 17 out of 148 industries.
What do These Ratings Mean?
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What’s Happening With Prometheus Biosciences Inc Stock Today?
Prometheus Biosciences Inc (RXDX) stock is unmoved 0% while the S&P 500 is up 0% as of 11:55 AM on Friday, Jun 9. RXDX is unmoved $0.00 from the previous closing price of $198.98 on volume of 127,292 shares. Over the past year the S&P 500 is higher by 6.88% while RXDX is up 655.14%. RXDX lost -$3.52 per share the over the last 12 months.
Click Here to get the full Stock Report for Prometheus Biosciences Inc stock.